SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : January Effect 2004 -- Ignore unavailable to you. Want to Upgrade?

To: semi_infinite who wrote (31)12/30/2003 1:45:37 PM
From: Biomaven  Read Replies (1) | Respond to of 55
 
The option premiums on RGEN were very high and I sold Jan 5 puts on RGEN as well as buying stock.

I hope you are aware that RGEN has a binary event scheduled for early January - the results of a key trial are likely to be announced. The stock will likely either double or halve depending on the results.

Peter



To: semi_infinite who wrote (31)12/30/2003 5:46:34 PM
From: Capt  Respond to of 55
 
BRCD has two conferances next week...



To: semi_infinite who wrote (31)1/31/2004 8:59:00 PM
From: semi_infinite   Respond to of 55
 
~N had the right idea in abstaining from JE2004. BRCD CPST RGEN VITA are the ones I bought and here are the results from 12/31 - 1/30 closing basis:

BRCD 5.78 6.40 +10.7%
CPST 1.86 2.17 +16.7
RGEN 4.37 3.33 -23.8
VITA 3.21 3.25 +1.2

Average change +0.6%
Nasdaq composite +3.1%

Of the 4 above, I kept VITA and RGEN but I expect all my RGEN will be assigned on Feb options expiration.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News